TKI vs relapse after HSCT: is the jury still out?
- PMID: 33031524
- DOI: 10.1182/blood.2020007021
TKI vs relapse after HSCT: is the jury still out?
Comment on
-
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL.Blood. 2020 Oct 8;136(15):1786-1789. doi: 10.1182/blood.2019004685. Blood. 2020. PMID: 32492706 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources